Ewing sarcoma treatment: a gene therapy approach

Sergey Tsibulnikov1, Daria Fayzullina1, Irina Karlina1

  • 1Group of Experimental Biotherapy and Diagnostics, Institute for Regenerative Medicine, World-Class Research Centre "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow State Medical University, Moscow, 119991, Russia.

Cancer Gene Therapy
|April 10, 2023
PubMed

Insights

Ewing sarcoma (ES) is an aggressive cancer. Gene therapy targeting fusion genes offers promising treatment strategies by focusing on specific molecules and delivery methods.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ewing sarcoma (ES) is a highly aggressive cancer.
  • ES is characterized by specific chromosomal translocations creating fusion genes.
  • Fusion genes and their protein products are key drivers of ES development.

Purpose of the Study:

  • To review active molecules for gene therapy in ES.
  • To explore various gene therapy delivery methods for ES treatment.
  • To provide a comprehensive overview of current gene therapy strategies for ES.

Main Methods:

  • Extensive literature review.
  • Analysis of scientific publications on ES gene therapy.
  • Synthesis of information on therapeutic targets and delivery systems.

Main Results:

  • Identified numerous active molecules (nucleotides, proteins) as potential gene therapy targets.
  • Detailed various gene therapy delivery methods suitable for ES.
  • Highlighted the necessity of both target molecule selection and effective delivery for successful treatment.

Conclusions:

  • Fusion genes in ES are viable targets for gene therapy.
  • Successful ES gene therapy requires careful selection of therapeutic molecules and efficient delivery strategies.
  • Further research into targeted gene therapies holds significant promise for treating Ewing sarcoma.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.6K